LUMIFY

bausch & lomb inc🇨🇦 Health Canada

Approval Id: 458a2531a09978a0
Drug Approval Canada Name: LUMIFY
Product Name: LUMIFY
Status: Marketed
Status Date: 2022-07-05
Original Market Date: 2022-07-05
Din: 02517698
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: OTC
Ahfs: 52:40.04
Atc Original: S01EA05 BRIMONIDINE
Atc Name: s 01 ea 05
Aig Number: 0131859004
Company Name: bausch & lomb inc
Company Address: 1400 N Goodman Street, Rochester, New York, United States, 14609

BRIMONIDINE TARTRATE

0.025 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

458a2531a09978a0

Type

Standard